RE:RE:Pancreatic cancer usually its better to buy after RS...
on another hand after last RS we saw a pop due the fact not all institution could trade it and it created a shortage of shares...
In this case investor know its going to Nasdaq as a pure cd47 play and maybe this RS will be seen as positive when news gets out
Maybe other long time holders can share their sentiment...